Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Beloveza – page 2

195 clinical trials in Beloveza, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Beloveza at a glance
195
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

195 trials in Beloveza

Open in trial search

A study testing duvakitug for patients with moderately to severely active ulcerative colitis

Investigational
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Colorectal cancer+1

Recruiting

Study of NGM120 in patients with colorectal cancer and cancer cachexia: Evaluating effects on body weight

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:NGM120
  • Sponsor:Ngm Biopharmaceuticals Inc.

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Study of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Delgocitinib
  • Sponsor:Leo Pharma A/S

Crohn's disease

Recruiting

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC

Cardiac failure

Recruiting

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:BHV-7000
  • Sponsor:Biohaven Therapeutics Ltd.

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Beloveza

What the registry says about research in the country

01 Cardiovascular Research

Clinical research focusing on Atrial Fibrillation management and stroke prevention. The studies aim to evaluate new therapeutic approaches for preventing cardioembolic events in patients with cardiac arrhythmias.

  • Stroke Prevention
  • Cardiac Arrhythmia Management
  • Cardioembolic Event Prevention

These investigations represent significant advancement in cardiovascular medicine, exploring innovative treatments for patients with heart rhythm disorders.

02 Thrombosis Prevention

Groundbreaking research evaluating new approaches in anticoagulation therapy. The trials focus on comparing novel treatments with established medications for preventing blood clots and related complications.

  • Blood Clot Prevention
  • Systemic Embolism Management
  • Comparative Treatment Studies

These studies aim to expand treatment options for patients requiring long-term anticoagulation therapy.

03 Clinical Outcomes Research

Investigation of therapeutic efficacy in preventing serious cardiovascular complications. The research evaluates non-CNS systemic embolism and stroke prevention strategies.

  • Treatment Effectiveness
  • Patient Safety Evaluation
  • Comparative Clinical Outcomes

This research contributes to advancing evidence-based treatment protocols in cardiovascular medicine.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.